14 November 2024
The new Sydney facility is expected to support GenScript’s ability to serve customers across the region, ensuring faster and more efficient delivery of research reagents and products. GenScript intends to support Australian researchers and biotech companies in streamlining permit applications, customs clearance, tax payments, and procurement processes. The Sydney site will also enable next-day shipping for high-demand products such as off-the-shelf mRNA, growth factors, Cas proteins, and more.